No correlation was found between hemoglobin difference, biochemical parameters, and biomarkers.<h4>Conclusion</h4>Desidustat was non-inferior to erythropoietin in treating anemia of dialysis-naïve CKD patients. This evidence concerns the gene EPO and anemia (phenotype).